Rapid Therapeutic Science Laboratories(RTSL)
$0.010.00 (-15.38%)
RTSL
Rapid Therapeutic Science Laboratories financials statements
$0.01
At close:0.00 (-15.38%)
Rapid Therapeutic Science Laboratories (RTSL) Income Statement
28 Followers
Rapid Therapeutic Science Laboratories Income Statement
Last quarter (Q2 2023), Rapid Therapeutic Science Laboratories's total revenue was $0.00. In Q2, Rapid Therapeutic Science Laboratories's net income was $46.42K. See Rapid Therapeutic Science Laboratories’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 22 | Dec 21 | Mar 20 | Mar 18 |
|---|---|---|---|---|
| $ 0.00 | $ 534.00 | $ 9.14K | $ 0.00 | |
| $ 0.00 | $ 334.00 | $ 1.98K | $ 0.00 | |
| $ 1.26M | $ 2.17M | $ 169.69K | $ 152.07K | |
| Depreciation and Amortization | $ 23.97K | $ 55.86K | $ 37.50K | $ 16.39K |
| $ -1.24M | $ -2.11M | $ -132.19K | $ -135.68K | |
| $ -1.26M | $ -2.17M | $ -169.69K | $ -2.52M | |
| $ -531.39K | $ -697.59K | $ 1.38K | $ -2.37M | |
| $ -1.79M | $ -2.87M | $ -348.84K | $ -2.55M | |
| $ -1.69M | $ -4.20M | $ -348.84K | $ -2.55M | |
| Per Share Metrics | ||||
| Basic EPS | $ -0.22 | $ -0.55 | $ -7.24 | $ -25.88 |
| Diluted EPS | $ -0.22 | $ -0.55 | $ -7.24 | $ -25.88 |
| Weighted Average Shares Outstanding | 7.75M | 7.63M | 48.16K | 98.64K |
| Weighted Average Shares Outstanding (Diluted) | 7.75M | 7.63M | 48.16K | 98.64K |
Currency in USD

